These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Aldosterone antagonism studies in the rhesus monkey. Hofmann LM, Pedrera HA, Suleymamov OD. J Pharmacol Exp Ther; 1977 Jul; 202(1):216-20. PubMed ID: 406381 [Abstract] [Full Text] [Related]
4. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone? Mahmud A, Mahgoub M, Hall M, Feely J. Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838 [Abstract] [Full Text] [Related]
5. Antagonism of aldosterone in normal subjects by Ro 12-2503 and spironolactone. Dux S, Rosenfeld J, Cocco G, Chu D, Gasser DF. Arzneimittelforschung; 1982 Dec; 32(2):164-9. PubMed ID: 7199923 [Abstract] [Full Text] [Related]
9. Interactions of spironolactone and hydrochlorothiazide with aspirin in the rat and dog. Hofmann LM, Krupnick MI, Garcia HA. J Pharmacol Exp Ther; 1972 Jan; 180(1):1-5. PubMed ID: 5010414 [No Abstract] [Full Text] [Related]
12. The renal action of spirorenone and other 6 beta,7 beta; 15 beta,16 beta-dimethylene-17-spirolactones, a new type of steroidal aldosterone antagonists. Casals-Stenzel J, Buse M, Wambach G, Losert W. Arzneimittelforschung; 1984 Jan; 34(3):241-6. PubMed ID: 6329237 [Abstract] [Full Text] [Related]
14. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. Preston RA, Norris PM, Alonso AB, Ni P, Hanes V, Karara AH. Menopause; 2007 Jan; 14(3 Pt 1):408-14. PubMed ID: 17224857 [Abstract] [Full Text] [Related]
17. The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters. Kaşifoğlu T, Yalçin AU. Anadolu Kardiyol Derg; 2006 Jun; 6(2):143-7. PubMed ID: 16766279 [Abstract] [Full Text] [Related]